Wei Zhang

ORCID: 0000-0001-5895-2643
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Gastric Cancer Management and Outcomes
  • Helicobacter pylori-related gastroenterology studies
  • Vascular Malformations and Hemangiomas
  • Gastrointestinal disorders and treatments
  • Mycotoxins in Agriculture and Food
  • Hematopoietic Stem Cell Transplantation
  • Antifungal resistance and susceptibility
  • Veterinary medicine and infectious diseases
  • Bacterial biofilms and quorum sensing
  • Lipoproteins and Cardiovascular Health
  • Ginkgo biloba and Cashew Applications
  • Multiple Myeloma Research and Treatments
  • Vascular Malformations Diagnosis and Treatment
  • Appendicitis Diagnosis and Management
  • Immunotherapy and Immune Responses
  • Head and Neck Surgical Oncology
  • Ocular Infections and Treatments
  • Pharmaceutical Economics and Policy
  • Fungal Biology and Applications
  • Antimicrobial Resistance in Staphylococcus

Chinese Academy of Medical Sciences & Peking Union Medical College
2021

Peking University First Hospital
2021

Peking University
2021

Hebei North University
2021

Peking Union Medical College Hospital
2021

Tan Tock Seng Hospital
2020

Shanghai Jiao Tong University
2016

Xiaomi (China)
2016

Wuhan University
2015

To compare the efficacy and safety of bismuth-containing quadruple therapy with tetracycline or amoxicillin for rescue treatment Helicobacter pylori.The study was a non-inferiority trial H. pylori eradication at least two previous failures. Subjects were randomized to receive 14-day b.i.d. lansoprazole 30 mg bismuth 220 mg, plus metronidazole 400 q.i.d 1 g t.i.d (amoxicillin group) 500 (tetracycline group). Antimicrobial susceptibility assessed by agar-dilution method. Primary outcome 6...

10.1038/ajg.2016.443 article EN The American Journal of Gastroenterology 2016-09-27

Abstract Background Antibiotic resistance is the main cause of Helicobacter pylori ( H . ) treatment failure. This study aimed to explore characteristics antibiotic isolates in Beijing last 8 years and estimate impact previous eradication failure on patterns. Materials methods retrospective included data from a single center 2013 2020. susceptibility 365 clinical was tested for amoxicillin, clarithromycin, metronidazole, levofloxacin, moxifloxacin, tetracycline. The patients their history...

10.1111/hel.12804 article EN Helicobacter 2021-04-16

Ginkgo biloba extract (GBE) is one of the most widely used herbal medicines in world. It often administered combination with statins to treat diseases, especially some nervous system disorders. We aimed investigate influences GBE on pharmacokinetics and efficacy atorvastatin, which are currently unclear.Sixteen volunteers received a single oral dose 40 mg followed by wash-out period at least 5 days. Then took 360 daily for 14 days, atorvastatin. Serial blood samples obtained over 48 h after...

10.3109/00498254.2012.661100 article EN Xenobiotica 2012-03-01

Diutina catenulata (Candida catenulata) is an ascomycete yeast species widely used in environmental and industrial research capable of causing infections humans animals. At present, there are only a few studies on D. catenulata, further required for its more in-depth characterization analysis. Eleven strains collected from China Hospital Invasive Fungal Surveillance Net (CHIF-NET) the CHIF-NET North Program were identified using matrix-assisted laser desorption ionization-time flight mass...

10.3389/fcimb.2021.739496 article EN cc-by Frontiers in Cellular and Infection Microbiology 2021-10-29

Background: Methicillin-resistant Staphylococcus aureus (MRSA) is a growing clinical problem in rehabilitation hospitals, where patients stay for extended periods intensive therapy. In addition to cutaneous sites, the nares could be source nosocomial MRSA transmission. Decolonization of nasal and reservoirs reduce acquisition. We evaluated effectiveness topical intranasal octenidine gel, coupled with universal chlorhexidine baths, reducing acquisition an extended-care facility. Methods:...

10.1017/ice.2020.888 article EN Infection Control and Hospital Epidemiology 2020-10-01
Coming Soon ...